Jardiance 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FQRJA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,302
Award facts
- Contract value 100% obligated
- $3,302.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a firm fixed price of $3,302.17 and an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a small-value transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio supporting federal medical procurement. The contract is a child order issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering a wide range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Jardiance—a diabetes medication—exemplifies the routine pharmaceutical supply operations executed through AmerisourceBergen's DLA framework, which enables flexible fulfillment of military healthcare needs through open and competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DB25FQRJA?
SPE2DB25FQRJA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FQRJA worth?
The government has obligated $3,302 on SPE2DB25FQRJA.
Is contract SPE2DB25FQRJA an order under another contract?
Yes. SPE2DB25FQRJA is a delivery order under SPE2DB25D2207, an indefinite delivery contract.
Was contract SPE2DB25FQRJA competed?
The extent of competition for SPE2DB25FQRJA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award